Q1 2026 · 13F-HR
HSG Holding Ltdholdings as filed
Filed 2026-05-15 · accession 0001193125-26-226714
$1.62B
Reported value
20
Positions
2026-03-31
Period end
The Brief · HSG Holding Ltd · Q1 2026
AI · grounded in 13F
HSG Holding Ltd established a new position in PONY worth $100.1M. The fund also increased its stake in CRCL by 114.35% and opened a new position in YIMUTIAN INC valued at $543,846. These moves contributed to a portfolio of 20 positions with total assets under management of $1.62B.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 722304102 | PDD | PDD HOLDINGS INC | $1.14B | 70.4% | 11,348,426 | Common | SOLE |
| 482497104 | BEKE | KE HLDGS INC | $107.6M | 6.64% | 1,939,017 | Common | SOLE |
| 732908108 | PONY | PONY AI INC | $100.1M | 6.18% | 7,538,358 | Common | SOLE |
| 36118L106 | FUTU | FUTU HLDGS LTD | $65.4M | 4.03% | 740,352 | Common | SOLE |
| G9572D103 | BULL | WEBULL CORP | $55.2M | 3.41% | 7,053,639 | Common | SOLE |
| 172573107 | CRCL | CIRCLE INTERNET GROUP INC | $48.7M | 3.00% | 669,200 | Common | SOLE |
| 48553T106 | BZ | KANZHUN LIMITED | $27.8M | 1.71% | 1,900,000 | Common | SOLE |
| 25445D101 | DDL | DINGDONG CAYMAN LTD | $26.3M | 1.63% | 10,091,839 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $14.0M | 0.86% | 663,308 | Common | SOLE |
| 16954L204 | COE | 51TALK ONLINE EDUCATION GROU | $7.8M | 0.48% | 474,901 | Common | SOLE |
| G8656L130 | THCH | TH INTERNATIONAL LIMITED | $7.5M | 0.47% | 2,900,606 | Common | SOLE |
| 54572F101 | LOT | LOTUS TECHNOLOGY INC | $6.3M | 0.39% | 4,834,099 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $6.2M | 0.38% | 266,062 | Common | SOLE |
| G11448100 | BTDR | BITDEER TECHNOLOGIES GROUP | $2.9M | 0.18% | 293,732 | Common | SOLE |
| 005329107 | ADAG | ADAGENE INC | $2.0M | 0.13% | 1,343,364 | Common | SOLE |
| 91864C107 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $1.2M | 0.07% | 1,420,473 | Common | SOLE |
| 055474209 | SLAI | SOLAI LIMITED | $627,264 | 0.04% | 350,427 | Common | SOLE |
| 985915107 | — | YIMUTIAN INC | $543,846 | 0.03% | 3,442,060 | Common | SOLE |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $73,104 | 0.00% | 152,299 | Common | SOLE |
| 12233L206 | BNR | BURNING ROCK BIOTECH LTD | $62,363 | 0.00% | 21,212 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.